Results 21 to 30 of about 896,879 (225)

NDM-1- and OXA-23-producing Acinetobacter baumannii in wastewater of a Nigerian hospital

Microbiology Spectrum, 2023
Carbapenem-resistant Acinetobacter baumannii spp. are increasingly important pathogens with limited treatment options, and there is limited knowledge on the environmental factors contributing to their spread.
Erkison Ewomazino Odih, Gabriel Temitope Sunmonu, Iruka N. Okeke, Anders Dalsgaard   +3 more
doaj   +1 more source

Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii

Journal of Global Antimicrobial Resistance, 2022
: Objectives: This study aimed to investigate the synergistic activity of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii collected from China.
Yun Li, Lanqing Cui, Feng Xue, Qing Wang, Bo Zheng   +4 more
doaj   +1 more source

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii [PDF]

Frontiers in Microbiology, 2014
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a carbon source. Moreover it resists desiccation. Carbapenems, a β-lactam, are the most
Tiwari, Vishvanath, Tiwari, Monalisa
openaire   +3 more sources

High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study

Revista da Sociedade Brasileira de Medicina Tropical, 2022
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a growing threat to public health. Methods: A 3-year retrospective study was conducted to evaluate the prevalence and lethality of multidrug-resistant (MDR) A.
Mariana Neri Lucas Kurihara, Romário Oliveira de Sales, Késia Esther da Silva, Gerlaine Damasceno Silva, Maria Carolina Tazinazzo Mansano, Fuad Fayez Mahmoud, Simone Simionatto   +6 more
doaj   +1 more source

Insights on carbapenem-resistant Acinetobacter baumannii [PDF]

Acta Biologica Szegediensis, 2021
Acinetobacter baumannii (A. baumannii) is an important nosocomial pathogen, which may be a causative agent in a wide-range of human pathologies. Carbapenems are usually considered the last safe and effective choice of drugs for the treatment of Gram-negative infections. The emergence of carbapenem-resistant A.
Matthew Gavino Donadu, Stefania Zanetti, Ádám László Nagy, Ibrahim Barrak, Márió Gajdács   +4 more
openaire   +3 more sources

Detection of Genes Encoding Metallo-beta-lactamases in Carbapenem Resistant Acinetobacter baumannii [PDF]

Journal of Kerman University of Medical Sciences, 2021
Background: Drug resistant Acinetobacter baumannii have emerged as a major problem in many hospitals and intensive care units. The aim of this study was to determine the antibiotic resistance pattern and the prevalence of metallo-beta-lactamase genes ...
Fatemeh karami, Razieh Nazari, Hasan Adeli   +2 more
doaj   +1 more source

Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, England [PDF]

, 2014
Background: Multidrug-resistant Acinetobacter baumannii commonly causes hospital outbreaks. However, within an outbreak, it can be difficult to identify the routes of cross-infection rapidly and accurately enough to inform infection control.
Chan, Jacqueline, Beryl Oppenheim, Chan, Jacqueline Z-M, Constantinidou, Chrystala, Bradley, Craig, Halachev, Mihail R, Pallen, Mark J, Pallen, Mark J., Nicola Cumley, Matthew Smith-Banks, Mihail R Halachev, Smith-Banks, Matthew, Halachev, Mihail R., Jacqueline Z-M Chan, Oppenheim, Beryl, Craig Bradley, Constantinidou, Chrystala I, Chrystala I Constantinidou, Cumley, Nicola, Mark J Pallen   +19 more
core   +1 more source

Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend

International Journal of Infectious Diseases, 2019
Background: Bacteraemia due to carbapenem-resistant gram-negative bacteria is challenging. This study examined the burden of carbapenem and colistin resistance in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii bacteraemia in ...
A. Balkhair, Z. Al-Muharrmi, B. Al’Adawi, I. Al Busaidi, H.B. Taher, T. Al-Siyabi, M. Al Amin, K.S. Hassan   +7 more
doaj   +1 more source

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital [PDF]

Brazilian Journal of Microbiology, 2009
Nineteen clonally related imipenem-resistant Acinetobacter baumannii isolates were recovered from eight intensive care unit patients. All isolates harboured bla OXA-51-like β-lactamase genes and showed the absence of 22 kDa fraction in outer membrane porin profile analysis.
Takagi, E.H., Lincopan, N., Cassettari, V.C., Passadore, L.F., Mamizuka, E.M., Martinez, M.B.   +5 more
openaire   +4 more sources

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance [PDF]

Clinical Infectious Diseases, 2015
With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging.Patients with infection or colonization due to colistin-resistant A. baumannii were identified at a hospital system in Pennsylvania. Clinical data were collected from electronic medical records.
Zubair A, Qureshi, Lauren E, Hittle, Jessica A, O'Hara, Jesabel I, Rivera, Alveena, Syed, Ryan K, Shields, Anthony W, Pasculle, Robert K, Ernst, Yohei, Doi   +8 more
openaire   +2 more sources